Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biofrontera (BFRI) Receivables: 2020-2024

Historic Receivables for Biofrontera (BFRI) over the last 5 years, with Dec 2024 value amounting to $5.3 million.

  • Biofrontera's Receivables fell 38.55% to $3.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $16.5 million, marking a year-over-year decrease of 17.65%. This contributed to the annual value of $5.3 million for FY2024, which is 33.25% down from last year.
  • Latest data reveals that Biofrontera reported Receivables of $5.3 million as of FY2024, which was down 33.25% from $8.0 million recorded in FY2023.
  • Biofrontera's Receivables' 5-year high stood at $12.4 million during FY2021, with a 5-year trough of $3.3 million in FY2020.
  • Over the past 3 years, Biofrontera's median Receivables value was $8.0 million (recorded in 2023), while the average stood at $7.8 million.
  • In the last 5 years, Biofrontera's Receivables spiked by 277.96% in 2021 and then plummeted by 33.25% in 2024.
  • Biofrontera's Receivables (Yearly) stood at $3.3 million in 2020, then skyrocketed by 277.96% to $12.4 million in 2021, then dropped by 17.56% to $10.2 million in 2022, then fell by 22.31% to $8.0 million in 2023, then slumped by 33.25% to $5.3 million in 2024.